{"schema_version":"1","generated_at":"2026-11-04T20:01:52.436Z","data_as_of":null,"url":"https://www.findmykol.com/kol/amany-keruakous","json_url":"https://www.findmykol.com/kol/amany-keruakous/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"amany-keruakous","name":"Amany Keruakous","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Augusta University","institution_url":"https://www.findmykol.com/institution/augusta-university","city":"Augusta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1821482720","orcid":"0000-0002-7205-3975","openalex":"A5037863137"},"summary":"Amany Keruakous is an Oncology physician affiliated with Augusta University. OpenAlex indexes 104 publications with 331 citations (h-index 8); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":104,"cited_by_count":331,"h_index":8,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07085728","title":"Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Eastern Cooperative Oncology Group","source_url":"https://clinicaltrials.gov/study/NCT07085728","trial_url":"https://www.findmykol.com/trial/NCT07085728"},{"nct":"NCT06142396","title":"Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure","phase":"EARLY_PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Augusta University","source_url":"https://clinicaltrials.gov/study/NCT06142396","trial_url":"https://www.findmykol.com/trial/NCT06142396"},{"nct":"NCT05846880","title":"VitD3 Supplementation in Patients With Multiple Myeloma","phase":"EARLY_PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Amany Keruakous, MD, MS.","source_url":"https://clinicaltrials.gov/study/NCT05846880","trial_url":"https://www.findmykol.com/trial/NCT05846880"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":25,"shown":3,"withheld":22,"rows":[{"payer":"Janssen","program_year":2025,"amount_usd":278428.6,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1821482720"},{"payer":"Bristol Myers Squibb","program_year":2025,"amount_usd":68416.76,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1821482720"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":12935.08,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1821482720"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1821482720","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":40,"classes_total":2,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":29.2,"drugs":[{"name":"Oxycodone Hcl","share_pct":80.7},{"name":"Oxycontin","share_pct":19.3}],"max_beneficiaries":null},{"class":"Gabapentinoids","setting":"prescribed","share_pct":10.8,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":26.2,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":26.2,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":14}]},{"area":"Cancer & immunology","share_pct":25.6,"classes_total":1,"classes":[{"class":"Thalidomide Analog","setting":"prescribed","share_pct":25.6,"drugs":[{"name":"Lenalidomide","share_pct":78},{"name":"Revlimid","share_pct":22}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Real-World Use of Prophylactic Anakinra to Mitigate CRS and ICANS In CAR-T Therapy","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.256","status":"verified"},{"title":"Practical Management of Adverse Events Associated with Bispecific Antibodies for the Treatment of Multiple Myeloma: A Qualitative Interview Study","year":2026,"journal":"medRxiv","source_url":"https://doi.org/10.64898/2026.04.24.26350878","status":"verified"},{"title":"Applying learning science principles (LSP) in a workshop (WS) for hematology and oncology (HemOnc) trainees (HOT) about how to use artificial intelligence (AI) in medical education (MedEd) and clinical practice (CP).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.9030","status":"verified"},{"title":"Finding Hope, One Breath at a Time","year":2026,"journal":"American Society of Clinical Oncology Educational Book","source_url":"https://doi.org/10.1200/edbk-26-00005","status":"verified"},{"title":"PA-395 Real-World Evaluation of Prophylactic Anakinra for Toxicity Mitigation in BCMA CAR-T Therapy","year":2026,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(26)03757-2","status":"verified"}],"source":"works"},"contact":{"address_1":"1120 15TH ST","city":"Augusta","state":"GA","zip":"309120004","phone":"706-721-8623","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1821482720","source":"identity"},"similar":[{"name":"Neal Weintraub","slug":"neal-weintraub","institution":"Augusta University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/neal-weintraub","json_url":"https://www.findmykol.com/kol/neal-weintraub/profile.json"},{"name":"Askiel Bruno","slug":"askiel-bruno","institution":"Augusta University","specialty":"Neurology","url":"https://www.findmykol.com/kol/askiel-bruno","json_url":"https://www.findmykol.com/kol/askiel-bruno/profile.json"},{"name":"Satish Rao","slug":"satish-rao","institution":"Augusta University","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/satish-rao","json_url":"https://www.findmykol.com/kol/satish-rao/profile.json"},{"name":"Avirup Guha","slug":"avirup-guha","institution":"Augusta University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/avirup-guha","json_url":"https://www.findmykol.com/kol/avirup-guha/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":22,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-03-23","provider_certified":"2021-03-23","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}